Affiliate-supportedIndependent editorialWe never sell medicationSee how
3-way comparison
Side-by-side breakdown — efficacy, cost, regulatory status, and who each option fits best.
| Attribute | |||
|---|---|---|---|
| Generic name | semaglutide (compounded) | tirzepatide (compounded) | semaglutide |
| Drug class | — | — | — |
| Regulatory status | Compounded | Compounded | FDA approved |
| Manufacturer | Various compounding pharmacies | Various compounding pharmacies | Novo Nordisk |
| Avg retail price | $250/mo | $299/mo | $1349/mo |
| Without insurance | $99–$350/mo | $149–$399/mo | $1349–$1500/mo |
| Savings card max | $0/mo | $0/mo | $0/mo |
| Shortage status |
| not_listed |
| not_listed |
| resolved |
(semaglutide (compounded)), (tirzepatide (compounded)), and (semaglutide) are GLP-1 medications used for weight management or type 2 diabetes. Key differences: is compounded, is compounded, is FDA-approved.
Effectiveness varies by individual. In clinical trials, tirzepatide-based drugs (Mounjaro, Zepbound) produced ~22% average body-weight loss vs ~15% for semaglutide-based (Ozempic, Wegovy). Discuss with your prescriber.
Cash retail price: $250/mo · $299/mo · $1349/mo. Compounded versions through telehealth typically run 60-80% less.
Drill down into any pair from the three above for deeper side-by-side analysis.
Dose conversion + transition timeline for each directional switch.